0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter | 
Lisa-Ann Fraser, MD, MSc; Kuan Liu, MMath; Kyla L. Naylor, MES; et al.
JAMA Intern Med. 2015;175(3):450-452. doi:10.1001/jamainternmed.2014.6930.

Invited Commentary | 
Noll L. Campbell, PharmD; Malaz A. Boustani, MD, MPH
JAMA Intern Med. 2015;175(3):408-409. doi:10.1001/jamainternmed.2014.7667.

Original Investigation | 
Shelly L. Gray, PharmD, MS; Melissa L. Anderson, MS; Sascha Dublin, MD, PhD; et al.
JAMA Intern Med. 2015;175(3):401-407. doi:10.1001/jamainternmed.2014.7663.
Includes: Supplemental Content

Invited Commentary | 
Lewis S. Nelson, MD; David N. Juurlink, MD, PhD
JAMA Intern Med. 2015;175(2):194-195. doi:10.1001/jamainternmed.2014.5260.

Original Investigation | 
Jean-Pascal Fournier, MD, PhD; Laurent Azoulay, PhD; Hui Yin, MSc; et al.
JAMA Intern Med. 2015;175(2):186-193. doi:10.1001/jamainternmed.2014.6512.
Includes: Supplemental Content

Original Investigation | 
Kenneth K. Mugwanya, MBChB, MS; Christina Wyatt, MD, MS; Connie Celum, MD, MPH; et al.
JAMA Intern Med. 2015;175(2):246-254. doi:10.1001/jamainternmed.2014.6786.
Includes: Supplemental Content

Original Investigation | 
Inmaculada Hernandez, PharmD; Seo Hyon Baik, PhD; Antonio Piñera, MD; et al.
JAMA Intern Med. 2015;175(1):18-24. doi:10.1001/jamainternmed.2014.5398.
Includes: CME, Supplemental Content

Special Communication | 
Daniel J. Morgan, MD, MS; Scott M. Wright, MD; Sanket Dhruva, MD
JAMA Intern Med. 2015;175(1):120-124. doi:10.1001/jamainternmed.2014.5444.
Includes: Supplemental Content

Research Letter | 
Michael D. Miedema, MD, MPH; Faye L. Lopez, MS, MPH; Michael J. Blaha, MD, MPH; et al.
JAMA Intern Med. 2015;175(1):138-140. doi:10.1001/jamainternmed.2014.6288.

Original Investigation | 
Meera Viswanathan, PhD; Leila C. Kahwati, MD, MPH; Carol E. Golin, MD; et al.
JAMA Intern Med. 2015;175(1):76-87. doi:10.1001/jamainternmed.2014.5841.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Susan B. Bressler, MD; Talat Almukhtar, MBChB; Anjali Bhorade, MD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Continued Learning  | 
A Patient With an Allergy Emergency
Steven M. Houser, MD; Catherine Weng, MD; Yi-Chun Liu, MD
JAMA Dermatology
Case Report/Case Series  | 
Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma
Cristina Carrera, MD, PhD; Joan A. Puig-Butillè, PhD; Gemma Tell-Marti, Ph; et al.
JAMA Dermatology
Case Report/Case Series  | 
Drug-Associated Dermatomyositis Following Ipilimumab Therapy:  A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade
Shirwa Sheik Ali, BSc; Allison L. Goddard, MD; Jason J. Luke, MD; et al.